SCN9A Gene Insensitivity to pain, channelopathy-associated NGS Genetic Test
Short Name: SCN9A NGS Test
Also known as: SCN9A Congenital Insensitivity to Pain Test, SCN9A Pain Insensitivity NGS Panel, Channelopathy-Associated NGS Genetic Test
SCN9A Gene Insensitivity to pain, channelopathy-associated NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically issued within 3 to 4 weeks from the date the sample reaches the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The purpose of this NGS genetic test is to identify pathogenic variants in the SCN9A gene associated with insensitivity to pain and channelopathy-associated pain disorders. It aids in confirming the diagnosis, assessing hereditary risk, and guiding family screening and genetic counselling.
- Test Code
- 4153
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are typically issued within 3 to 4 weeks from the date the sample reaches the laboratory.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Sample Collection
No special preparation is required. Fasting is not needed. Please carry a valid prescription or clinical referral if available. A genetic counselling session is recommended before the test to record the family history and draw a pedigree chart.
Method: Peripheral vein blood draw or FTA card spot
Laboratory Analysis
A small blood sample will be collected from a vein in the arm by a trained phlebotomist. If an FTA card is used, a few drops of blood will be applied to the card and allowed to dry.
Report Delivery
You can resume normal activities immediately. The sample will be labelled and transported to the DNA Labs India laboratory for processing.
Timeline: Reports are typically issued within 3 to 4 weeks from the date the sample reaches the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this NGS genetic test is to identify pathogenic variants in the SCN9A gene associated with insensitivity to pain and channelopathy-associated pain disorders. It aids in confirming the diagnosis, assessing hereditary risk, and guiding family screening and genetic counselling.
How to Prepare
- Submit the completed test request form and consent document.
- Provide a clinical history and family pedigree chart before sample collection.
- For FTA cards, let the blood spot air-dry completely before sealing in the zipper pouch.
- Maintain appropriate transport conditions as advised by the laboratory.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"As a clinician, I recommend this test when clinical signs of reduced pain sensitivity or a family history of channelopathy-associated pain disorders are present. Early molecular confirmation may help prevent silent injuries and guide genetic counselling. Obstetricians and gynaecologists may also consider this test for family-planning discussions when a parent is known to carry a pathogenic SCN9A variant."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Mislabelled sample
- Clotted blood sample
- Insufficient quantity of sample
- Sample received in an inappropriate container
- FTA card with insufficient blood spots
Understanding Your Results
Confirms molecular diagnosis of SCN9A-related pain insensitivity or channelopathy.
Action: Genetic counselling and targeted family screening are recommended.
SCN9A-associated cause is not identified in this sample.
Action: Other genetic and non-genetic causes should be considered by the treating physician.
Insufficient evidence exists to determine whether the variant is disease-causing.
Action: Family segregation studies and additional clinical correlation may be required.
Consult a clinical geneticist, neurologist, or obstetrician-gynaecologist if you notice reduced pain perception, recurrent painless injuries, temperature insensitivity, or if a first-degree relative has been diagnosed with SCN9A-related pain insensitivity. A genetic test may be recommended during family planning or prenatal counselling.
Limitations
- ⚠This test only analyses SCN9A and does not rule out other pain insensitivity genes.
- ⚠NGS may not detect all mutation types such as deep intronic mutations or large structural rearrangements.
- ⚠Variants of uncertain significance (VUS) may be reported and require further investigation.
- ⚠Clinical correlation with symptoms and family history is essential for accurate interpretation.
Risks & Considerations
- ●No significant clinical risk is associated with this DNA test.
- ●Minor bruising, discomfort, or bleeding at the blood collection site may occur.
Interfering Factors
- ●Contaminated or degraded DNA sample
- ●Sample mix-up or mislabelling
- ●Variants present in deep intronic regions not covered by standard NGS assay
- ●Large deletions or duplications that may require additional copy-number analysis
Compare With Similar Tests
| Test | SCN9A Gene Insensitivity to pain, channelopathy-associated NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | SCN9A Gene Insensitivity to pain, channelopathy-associated NGS Genetic Test |
Frequently Asked Questions
What is the SCN9A gene insensitivity to pain NGS genetic test?
What are the symptoms of SCN9A-related pain insensitivity?
Why is NGS used for this test?
What type of sample is needed?
Is fasting required before the test?
How long does it take to get the report?
What is the cost of this test?
Does DNA Labs India provide raw data along with the clinical report?
Can this test help with family planning decisions?
Is the test covered by insurance?
Are there any risks from the test?
Who should consider this test?
Related Tests
Huntington Disease Mutation Detection Test
₹8,000Myotonic Dystrophy Type 1 Test
₹8,500Nx Gen Sequencing: Duchenne & Becker Muscular Dystrophy Test
₹23,400Nx Gen Sequencing: Tuberous Sclerosis Complex Test
₹27,495MED25 Gene CMT2B2 NGS Genetic Test
₹20,000FLNA Gene Intestinal pseudoobstraction, neuronal NGS Genetic Test
₹20,000Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
